Search | IOVS | ARVO Journals

Showing 1 – 20 of 27

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Helena Margaret Anthonia Feenstra; Roselie M.H. Diederen; Martine J.C.M. Lamme; Sascha Fauser; Susan M. Downes; Reinier O. Schlingemann; Carel C B Hoyng; Elon H.C. van Dijk; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):37. doi:

ARVO Annual Meeting Abstract June 2022

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy

Joost Brinks; Elon H.C. van Dijk; Roula Tsonaka; Onno C. Meijer; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1180 – A0034. doi:

ARVO Annual Meeting Abstract June 2022

Results of focal photocoagulation in polypoidal choroidal vasculopathy patients from a Dutch referral center

Marc J. Sirks; Helena Margaret Anthonia Feenstra; Florentine R. de Vries; Greet Dijkman; Camiel J F Boon; Elon H.C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3768 – F0189. doi:

ARVO Annual Meeting Abstract June 2022

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

Camiel J F Boon; Helena Margaret Anthonia Feenstra; Jonathan Hensman; Theodora Gkika; Carel C B Hoyng; Roselie M.H. Diederen; Reinier O. Schlingemann; Susan M. Downes; Elon H.C. van Dijk

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3763 – F0184. doi:

ARVO Annual Meeting Abstract June 2021

Genome-wide transcriptional responses of human choroidal endothelial cells to corticosteroids as a model for central serous chorioretinopathy

Joost Brinks; Elon van Dijk; Szymon Kielbasa; Hailang Mei; Paul Quax; Onno Meijer; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):43. doi:

ARVO Annual Meeting Abstract June 2021

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

Helena Feenstra; Thomas Jurian van Rijssen; Roselie Diederen; Carel Hoyng; Reinier Schlingemann; Elon van Dijk; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2170. doi:

ARVO Annual Meeting Abstract July 2019

The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and treatment outcome

Elon Van Dijk; Simona Veselinovic; Danial Mohabati; Wing Chung; Greetje Dijkman; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1152. doi:

ARVO Annual Meeting Abstract July 2019

Changes on multimodal imaging after treatment with photodynamic therapy or high-density subthreshold micropulse laser in chronic central serous chorioretinopathy

Thomas Jurian van Rijssen; Leo C Hahn; Elon Van Dijk; Paula Scholz; Myrte Breukink; Eric H Souied; Robert E MacLaren; Giuseppe Querques; Sascha Fauser; Susan M. Downes; Carel C B Hoyng; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1155. doi:

ARVO Annual Meeting Abstract July 2019

Corticosteroids and central serous chorioretinopathy: the role of the mineralocorticoid and glucocorticoid receptor in human choroidal endothelial cells

Joost Brinks; Elon H.C. van Dijk; Onno C. Meijer; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4325. doi:

Biochemistry and Molecular Biology November 2018

The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy

PDF

Joost Brinks; Elon H. C. van Dijk; Mahmoud Habeeb; Aikaterini Nikolaou; Roula Tsonaka; Hendrika A. B. Peters; Hetty C. M. Sips; Arjanneke F. van de Merbel; Eiko K. de Jong; Robbert G. E. Notenboom; Szymon M. Kielbasa; Silvère M. van der Maarel; Paul H. A. Quax; Onno C. Meijer; Camiel J. F. Boon
TAGS: adrenal corticosteroids, central serous chorioretinopathy, chronic exertional compartment syndrome, endothelial cells, glucocorticoids, hydrocortisone, mineralocorticoids, antagonists, agonists, patient isolation
Invest. Ophthalmol. Vis. Sci.. 2018; 59(13):5682-5692. doi: https://doi.org/10.1167/iovs.18-25054

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2018

Pathophysiology of chemotherapy induced retinopathy

Elon H. Van Dijk

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4408. doi:

ARVO Annual Meeting Abstract July 2018

Genome-wide association study underlines the role of the complement system in chronic central serous chorioretinopathy

Rosa Schellevis; Elon H. Van Dijk; Myrte Breukink; Lebriz Altay; Bjorn Bakker; Bobby Koeleman; Lambertus Kiemeney; Dorine Swinkels; Jan Keunen; Sascha Fauser; Carel C B Hoyng; Anneke I Den Hollander; Camiel Boon; Eiko de Jong

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4983. doi:

ARVO Annual Meeting Abstract July 2018

Salivary alpha amylase activity is increased in active central serous chorioretinopathy

Lebriz Altay; Paula Scholz; Vasilena Sitnilska; Elon H. Van Dijk; Alberto M. Pereira; Femke M. van Haalen; Isha Akhtar; Camiel Boon; Sascha Fauser

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3128. doi:

ARVO Annual Meeting Abstract July 2018

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

Thomas Jurian van Rijssen; Elon H. Van Dijk; Greet Dijkman; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3134. doi:

ARVO Annual Meeting Abstract July 2018

The effect of corticosteroids on human choroidal endothelial cells: a model to study central serous chorioretinopathy

Elon H. Van Dijk; Mahmoud Habeeb; Aikaterini Nikolaou; Joost Brinks; Roula Tsonaka; Hendrika Peters; Hetty Sips; Arjanneke van de Merbel; Eiko de Jong; Robbert Notenboom; Szymon Kielbasa; Silvère van der Maarel; Paul Quax; Onno Meijer; Camiel Boon

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1577. doi:

ARVO Annual Meeting Abstract June 2017

Fluorescein angiography and fundus autofluorescence imaging discrepancy in patients with chronic central serous chorioretinopathy

Vladimir Sheptulin; Danial Mohabati; Elon Van Dijk; Camiel J F Boon; Carel C B Hoyng; Konstantine Purtskhvanidze; Johann Roider

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1501. doi:

ARVO Annual Meeting Abstract June 2017

Potency assay for AAV-gene vectors in human iPSCs-derived retinas and donor retinas

Thilo Matthias Buck; Peter M Quinn; Celso Alves; Elon Van Dijk; Charlotte Ohonin; Camiel J F Boon; Jan Wijnholds

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4093. doi:

ARVO Annual Meeting Abstract June 2017

Systemic complement activation in central serous chorioretinopathy

Elon Van Dijk; Ngaisah Klar; Roula Tsonaka; Eiko de Jong; Cees van Kooten; Camiel J F Boon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5923. doi:

ARVO Annual Meeting Abstract June 2017

Choroidal layer thickness in central serous retinopathy

Jay Chhablani; Daren Hanumunthadu; Elon HC van Dijk; Sunila Dumpala; Bindu Rajesh; Ayesha Jabeen; Asiya Jabeen; Momin Ansari; Pooja Mehta; Shilpi Shah; Chintan Sarvaiya; Catherine Meyerele; Lihteh Wu; Alay Banker; Giridhar Anantharaman; Camiel JF Boon

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1295. doi:

ARVO Annual Meeting Abstract June 2017

Long-term phenotype changes in patients with chronic central serous chorioretinopathy.

Johann Roider; Konstantine Purtskhvanidze; Vladimir Sheptulin; Danial Mohabati; Elon HC van Dijk; Camiel J F Boon; Carel C B Hoyng

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1503. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy

Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy

Results of focal photocoagulation in polypoidal choroidal vasculopathy patients from a Dutch referral center

Spontaneous resolution of subretinal fluid in chronic central serous chorioretinopathy: the Fuji sign

Genome-wide transcriptional responses of human choroidal endothelial cells to corticosteroids as a model for central serous chorioretinopathy

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECTRA trial report No. 3

The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and treatment outcome

Changes on multimodal imaging after treatment with photodynamic therapy or high-density subthreshold micropulse laser in chronic central serous chorioretinopathy

Corticosteroids and central serous chorioretinopathy: the role of the mineralocorticoid and glucocorticoid receptor in human choroidal endothelial cells

The Effect of Corticosteroids on Human Choroidal Endothelial Cells: A Model to Study Central Serous Chorioretinopathy

Pathophysiology of chemotherapy induced retinopathy

Genome-wide association study underlines the role of the complement system in chronic central serous chorioretinopathy

Salivary alpha amylase activity is increased in active central serous chorioretinopathy

Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy

The effect of corticosteroids on human choroidal endothelial cells: a model to study central serous chorioretinopathy

Fluorescein angiography and fundus autofluorescence imaging discrepancy in patients with chronic central serous chorioretinopathy

Potency assay for AAV-gene vectors in human iPSCs-derived retinas and donor retinas

Systemic complement activation in central serous chorioretinopathy

Choroidal layer thickness in central serous retinopathy

Long-term phenotype changes in patients with chronic central serous chorioretinopathy.

To View More...

You must be signed into an individual account to use this feature.